# A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

> **NCT04668976** · PHASE2 · UNKNOWN · sponsor: **Benaroya Research Institute** · enrollment: 100 (estimated)

## Conditions studied

- Colorectal Cancer
- Cholangiocarcinoma

## Interventions

- **DEVICE:** Medtronic pump and Codman catheter
- **DRUG:** Floxuridine (FUDR)
- **DRUG:** Gemcitabine
- **DRUG:** Oxaliplatin
- **DRUG:** Irinotecan (CPT-11)
- **DRUG:** Fluorouracil
- **DRUG:** Anti-EGFR (Panitumumab or Cetuximab)

## Key facts

- **NCT ID:** NCT04668976
- **Lead sponsor:** Benaroya Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-25
- **Primary completion:** 2023-12
- **Final completion:** 2024-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04668976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04668976, "A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04668976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*